NEW YORK, Nov. 18 (GenomeWeb News) - CuraGen subsidiary 454 Life Sciences is offering a glimpse of one aspect of its next-generation sequencing technology, which has been under development - and under wraps - since 454's spin-out in 2000. The company said today that it has published its method to amplify genome fragments for sequencing in its massively parallel platform.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

A new analysis examines the gender gap among paper authors in the sciences and says it may take decades or more to close.

Researchers have uncovered signals of selection that may enable the Bajau people to free five hundreds of feet deep, Reuters reports.

In Science this week: paternally inherited cis-regulatory structural variants in autism, and more.

A new report outlines issues facing the implementation of personalized medicine in the UK, the Independent reports.